GSA Capital Partners LLP Has $2.14 Million Stock Position in ASP Isotopes Inc. (NASDAQ:ASPI)

GSA Capital Partners LLP lifted its holdings in ASP Isotopes Inc. (NASDAQ:ASPI) by 96.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 770,989 shares of the company’s stock after acquiring an additional 377,721 shares during the period. GSA Capital Partners LLP’s holdings in ASP Isotopes were worth $2,143,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of ASPI. Fielder Capital Group LLC bought a new stake in ASP Isotopes in the 2nd quarter valued at about $55,000. Rhumbline Advisers acquired a new stake in shares of ASP Isotopes in the second quarter valued at approximately $116,000. HTLF Bank boosted its stake in shares of ASP Isotopes by 197.0% in the second quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after buying an additional 70,000 shares during the period. Virtu Financial LLC grew its position in ASP Isotopes by 477.0% during the first quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after buying an additional 69,176 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new stake in ASP Isotopes during the second quarter worth approximately $381,000. 16.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. HC Wainwright cut their target price on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Canaccord Genuity Group began coverage on shares of ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 price objective for the company. Finally, Canaccord Genuity Group reissued a “buy” rating and issued a $4.50 target price on shares of ASP Isotopes in a report on Friday, October 18th.

ASP Isotopes Trading Down 5.7 %

Shares of ASPI opened at $8.27 on Tuesday. The company has a debt-to-equity ratio of 2.06, a quick ratio of 4.00 and a current ratio of 4.00. ASP Isotopes Inc. has a 52-week low of $1.45 and a 52-week high of $9.33. The firm has a market cap of $588.52 million, a price-to-earnings ratio of -13.13 and a beta of 3.88. The business’s fifty day moving average is $4.01 and its 200-day moving average is $3.59.

ASP Isotopes (NASDAQ:ASPI) last released its earnings results on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The business had revenue of $1.02 million during the quarter. Equities analysts anticipate that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.